Cyr61 has been shown to promote angiogenesis and tumor growth108, be an early biomarker of renal injury109 and plays a role in inhibiting vascular smooth muscle cell proliferation and neointimal hyperplasia110. The gene discussed is CCN1; the disease is neoplasm.